Table 3.
Multivariate regression analysis for risk factors related to ulcer healing.
| Variables | FAS population | PPS population | |||||
|---|---|---|---|---|---|---|---|
| Wald χ2 | P | OR (95% CI) | Wald χ2 | P | OR (95% CI) | ||
| Therapy | 20 mg ANA vs. 10 mg RAB | 0.154 | 0.695 | 0.788 (0.240–2.588) | 0.234 | 0.629 | 0.726 (0.198–2.658) |
| 40 mg ANA vs. 10 mg RAB | 0.003 | 0.958 | 0.967 (0.284–3.295) | 0.093 | 0.760 | 1.247 (0.302–5.158) | |
| H. pylori status | Negative vs. positive | 3.307 | 0.069 | 0.380 (0.134–1.078) | 4.628 | 0.031 | 0.273 (0.084–0.891) |
| Number of ulcers | 1 vs. 2 | 0.002 | 0.966 | 1.026 (0.308–3.418) | 0.556 | 0.456 | 1.628 (0.452–5.863) |
| Sex | Male vs. female | 0.067 | 0.795 | 1.150 (0.399–3.314) | 0.350 | 0.554 | 0.663 (0.170–2.586) |
ANA, Anaprazole; RAB, Rabeprazole; FAS, Full analysis set; PPS, per-protocol set.